Yale, Mayo and FDA experts aim to rethink heart failure tria...

A group of scientists from Yale University and the Mayo Clinic are to use an Apple Watch app in a bid to rethink clinical trial design in heart failure.

FDA clears Bayer’s Gadavist as first contrast agent for card...

Huami set to launch ECG watches outside China

Huami is to make its new crop of electrocardiogram smartwatches available to international markets, according to a press report.

Biotech Verve launches on mission to replace statins with CR...

Could CRISPR gene editing one day replace the need for cholesterol-lowering drugs such as statins?

Cholesterol drug from Sanofi/Regeneron gains US CV risk redu...

Sanofi and Regeneron’s Praluent cholesterol drug has been approved in the US to help prevent cardiovascular events, a new indication that will help it compete with Amgen’s rival from the sa

Bayer and J&J settle Xarelto lawsuits in US

Bayer and Johnson & Johnson have agreed to settle more than 25,000 US lawsuits worth more than $775 million alleging that blockbuster blood thinner Xarelto caused unstoppable and someti